glp-1 pathophysiology Frontiers Mechanism of action of GLP-1

10.1016/j.eclinm.2024.102782 6

In contrast, a recent meta-analysis on gastric emptying delay in 658 non-surgical patients treated with GLP1-Ras, regardless of indication, only found a short gastric emptying delay (~ 36 minutes) relative to standard perioperative fasting periods

Physician-prescribed topical formulations deliver the peptide exactly where the benefits occur, at therapeutic concentrations (2 to 10 percent or more), without systemic distribution

Gastrointestinal symptoms should be tracked, as persistent severe nausea, vomiting, or abdominal pain may indicate complications such as pancreatitis or gallbladder disease, which require immediate medical evaluation

The intersection of obesity treatment costs with GLP-1 medication expenses creates complex economic considerations for healthcare systems ^25